New Delhi [India], July 12 (ANI): The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) on Monday announced strong results of the study on neutralizing the activity of sera from individuals vacc
Moscow [Russia], March 14 (ANI/Sputnik): The Russian-made Sputnik V coronavirus vaccine has proven equally effective for all age groups, Alexander Gintsburg, the head of the Gamaleya research institute that developed the vaccine, said on Saturday.
Moscow [Russia], December 14 (ANI): The efficacy of the Sputnik V COVID-19 vaccine has been confirmed to be 91.4 per cent, based on data analysis of the final control point of clinical trials, announced the Gamaleya National Center of Epidemiology and Microbiology and the Russian Direct I
Moscow [Russia], November 27 (ANI/Sputnik): The Russian Gamaleya research institute has suggested UK pharmaceutical company AstraZeneca try to boost the efficacy of its COVID-19 vaccine, combining it with a shot of Russian COVID-19 vaccine Sputnik V.
Moscow [Russia], September 8 (ANI/Sputnik): The second batch of Russia's Sputnik V vaccine against COVID-19 for civil circulation is already being produced by the Gamaleya National Research Institute of Epidemiology and Microbiology, and the Federal Service for Surveillance in Healthcare (Ro
Moscow [Russia], September 8 (ANI/Sputnik): The first batch of the Sputnik V vaccine against COVID-19, developed by Russia's Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) has been released into civil circulation, regional del
Moscow [Russia], July 18 (Sputnik/ ANI): Russia's Gamaleya Institute of Epidemiology and Microbiology has produced a coronavirus vaccine that is patented and more advanced than Western competitors and will be happy to share the technology with foreign colleagues, should they require, the ins